Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sevion Therapeutics Inc (OTCQB:SVON)

0.30
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
0.11
Today|||52-Week Range
0.38
+113.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues100.0K75.0K75.0K0.00
 
 
 
 
Depreciation And Amortization349.7K177.1K93.4K44.1K
 
 
 
 
 
 
Operating ExpensesGross Income-----18.4K-44.1K
 
 
 
General Expenses6.7M7.7M3.5M2.2M
 
 
 
 
 
Other Operating Expenses0.00258.7K181.4K-66.0K
 
 
 
 
Research And Development3.3M4.8M2.1M689.6K
 
 
 
 
 
Total Operating Expenses7.0M8.2M3.8M2.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.9M-8.1M-3.7M-2.1M
 
 
 
 
 
Extraordinary Credit0.00458.4K2.2M--
 
 
 
Extraordinary Charge-2.2M-10.4M-7.5M-2.9M
 
 
 
 
 
Interest Expense On Debt85.6K0.000.00265.2K
 
 
 
Other Expenses0.00-2.8K-533.00-1.6M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.2M-18.1M-8.9M-6.8M
 
 
 
 
 
Income Taxes0.000.00-680.0K-1.0M
 
 
 
Preferred Dividend-4.6M-838.9K-179.2K-397.9K
 
 
 
 
 
Net Income-9.2M-18.1M-8.3M-5.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.5M14.4M20.3M23.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.5M14.4M20.3M23.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.53-$1.31-$0.42-$0.27
 
 
 
 
 
EPS Diluted-$2.53-$1.31-$0.42-$0.27